© 2005 by BMJ Publishing Group Ltd & British Society of Gastroenterology
COMMENTARY
Cancer cachexia syndrome
Thalidomide and cancer cachexia: old problem, new hope?
Correspondence to:
Correspondence to:
Dr M Stroud
Institute of Human Nutrition, Mail Point 113, F Level, Centre Block, Southampton General Hospital, Tremona Rd, Southampton SO16 6YD, UK; m.a.stroud@soton.ac.uk
Thalidomide is safe and may be effective in attenuating severe weight loss in patients with advanced pancreatic cancer. This may also grant benefit in terms of improved physical function
Keywords: thalidomide; cachexia; pancreatic cancer; weight loss; randomised controlled trial
| The first 150 words of the full text of this article appear below. |
The cancer cachexia syndrome is common. Significant weight loss occurs in approximately 50% of oncology patients, with even higher values in those with gastrointestinal tumours.1 In pancreatic cancer, approximately 80% of patients will become severely malnourished. The development of cachexia is not only distressing for patients and their families, it is also associated with a much worse clinical outcome. Malnourished patients undergoing surgery for cancer have morbidity and mortality rates of three to four times those of their better nourished counterparts,2 and wasted weakened patients also tolerate chemoradiation poorly. Ultimately, malnutrition itself can be considered to be the final cause of death in approximately 30% of cancer patients. It occurs once patients have lost about one third of their premorbid body weight.
Historical explanations for the causes of cancer induced wasting have been varied. Some experts have claimed that the dominant cause of weight loss is heightened
Relevant Article
- Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial
- J N Gordon, T M Trebble, R D Ellis, H D Duncan, T Johns, and P M Goggin
Gut 2005 54: 540-545.[Abstract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
